Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease

BACKGROUND: Plasma (p-)activin A is elevated in chronic kidney disease–mineral and bone disorder (CKD-MBD). Activin A inhibition ameliorates CKD-MBD complications (vascular calcification and bone disease) in rodent CKD models. We examined whether p-activin A was associated with major adverse cardiov...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordholm, Anders, Sørensen, Ida M H, Bjergfelt, Sasha S, Fuchs, Andreas, Kofoed, Klaus F, Landler, Nino E, Biering-Sørensen, Tor, Carlson, Nicholas, Feldt-Rasmussen, Bo, Christoffersen, Christina, Bro, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689128/
https://www.ncbi.nlm.nih.gov/pubmed/38046005
http://dx.doi.org/10.1093/ckj/sfad238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689128/
https://www.ncbi.nlm.nih.gov/pubmed/38046005
http://dx.doi.org/10.1093/ckj/sfad238

Ejemplares similares